OK, so I am a bit confused and looking for clarity. Does the whole HGEN changing its endpoint bode ill, well, or not affect CYDY and CD12? I realize that HGEN is in bed with big pharma and we're just the pesky pipsqueaks at the moment, but I would like to understand the big picture better.

Looks like our share price is dipping a bit today but then again, so is HGEN. If news of them changing their endpoint was great, wouldn't HGEN be going up?

Thanks in advance for the clarification, much appreciated.